Company intelligence / Profile preview

Jubilant

Noida, Uttar Pradesh, Indiajubilantcareer.jubl.com ↗

Ownership: Private
Employees: ~1996
Development stage: Commercial

Overview

Jubilant Pharmova is a global integrated pharmaceutical company with commercialized products in radiopharmaceuticals, allergy immunotherapy, generics, and contract manufacturing. It operates one of the largest radio-pharmacy networks in the US and is active in drug discovery and development for oncology and autoimmune indications. The company has a strong track record of partnerships with healthcare providers for nuclear medicine solutions[3][4].

Therapeutic areas: OncologyCardiovascularImmunologyNeurology
Modalities: Small moleculeBiologicRadiopharmaceutical
Industry: Biotech

Drug pipeline

1 asset

carya cordiformis pollen extract

Unknown

Partnerships

Simplified Imaging Solutions (nuclear medicine efficiency in the US)Cardiac Imaging (rubidium PET solutions)

Beyond the preview

Go deeper on Jubilant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jubilant.

Explore the full profile